Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)
Clinical trial NCT06621043 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06621043
- Sponsor
- Fenix Innovation Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2025-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.